BIOFIT2019 – very successful Business convention and Congress #BIOFIT2019
BIOFIT2019 – very successful Business convention and Congress #BIOFIT2019
Despite the strike, BIOFIT2019 in Marseille was a very successful edition with more than 1150 delegates, 13 000 meetings at the business convention, companies from 35 countries, 16 conferences, 4 hosted Events, 120 exhibitors.
This event give the opportunity for start-ups, mature companies and pharma to meet at human size.
A nice opportunity was been given to start-up companies to present their project at Start-up Slams.
4 of 50 companies have been awarded :
- The most innovative Start-up : MEDISIEVE, UK (https://www.medisieve.com/) MEDISIEVE develops a medical device to remove from the blood pathogen (bacteria in Sepsis, malaria, viruses, white blood cells from patients with leukemia).
- The most collaborative Start-up: ALCEDIAG, FR (https://www.alcediag-alcen.com/) ALCEDIAG develops blood-based diagnostic solutions for mental health (depression, bipolar disorder, ..) based on RNA editing, an epigenetic mecanism.
- The Best in services presentation: VELABS, DE (http://www.velabs-therapeutics.com/) Using microfluidic technology, VELABS accelerates the generation of antibodies against target molecules.
- The Best in Animal Health: AND Biopharma, NL/BE (https://andbiopharma.com/) From the observation that random DNA fragmentation had a inhibiting effect on the population of the same species, AND Biopharma works on early research project in agri-food but also in pharma, including antibiotics, cystic fibrosis, cancer, malaria, leishmania and intestinal worms.
Next edition will take place in Strabourg, France on December 1st & 2d 2020.
(https://www.biofit-event.com/)
BtoBioinnovation wishes you a Merry Christmas & Happy New Year.
Share :
Last News
- Note de réflexion de fin d’année
- EMA re-examines its opinion and approves Leqembi for the treatment of Alzheimer’s disease
- Le déclassement de la France
Events
News archives
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- March 2024
- February 2024
- January 2024
- November 2023
- September 2023
- July 2023
- April 2023
- March 2023
- January 2023
- December 2022
- November 2022
- October 2022
- August 2022
- June 2022
- May 2022
- April 2022
- March 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- October 2018
- June 2018
- May 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- September 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- June 2014
- May 2014
- April 2014
- March 2014
- January 2014
- November 2013
- September 2013
- July 2013
- May 2013
- April 2013
- March 2013
- January 2013
- December 2012
- November 2012
- October 2012
- March 2012